Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Precise Profiling of Liver Disease Patients With DPMAS Therapy, Treating Optimal Patients and Achieving Hard Endpoint: a Multicenter, Cluster-controlled Study (PADSTONE Study)

NCT05129904 is registered in ClinicalTrials.gov with Nanfang Hospital, Southern Medical University as lead sponsor.

NCT NCT05129904
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05129904 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Precise Profiling of Liver Disease Patients With DPMAS Therapy, Treating Optimal Patients and Achieving Hard Endpoint: a Multicenter, Cluster-controlled Study (PADSTONE Study)
Lead sponsor
Nanfang Hospital, Southern Medical University
Phase
Observational
Overall status
Active, not recruiting
Start date
September 15, 2021
Completion date
September 30, 2026
Enrollment
1,300 (estimated)
Sites
56

Conditions

As the registry lists them; a condition with its own page is linked.

dpmas therapy in liver disease patients